首页> 美国卫生研究院文献>Scientific Reports >Copper(II) ions affect the gating dynamics of the 20S proteasome: a molecular and in cell study
【2h】

Copper(II) ions affect the gating dynamics of the 20S proteasome: a molecular and in cell study

机译:铜离子会影响20S蛋白酶体的门控动力学:分子和细胞研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Due to their altered metabolism cancer cells are more sensitive to proteasome inhibition or changes of copper levels than normal cells. Thus, the development of copper complexes endowed with proteasome inhibition features has emerged as a promising anticancer strategy. However, limited information is available about the exact mechanism by which copper inhibits proteasome. Here we show that Cu(II) ions simultaneously inhibit the three peptidase activities of isolated 20S proteasomes with potencies (IC50) in the micromolar range. Cu(II) ions, in cell-free conditions, neither catalyze red-ox reactions nor disrupt the assembly of the 20S proteasome but, rather, promote conformational changes associated to impaired channel gating. Notably, HeLa cells grown in a Cu(II)-supplemented medium exhibit decreased proteasome activity. This effect, however, was attenuated in the presence of an antioxidant. Our results suggest that if, on one hand, Cu(II)-inhibited 20S activities may be associated to conformational changes that favor the closed state of the core particle, on the other hand the complex effect induced by Cu(II) ions in cancer cells is the result of several concurring events including ROS-mediated proteasome flooding, and disassembly of the 26S proteasome into its 20S and 19S components.
机译:由于它们的代谢改变,癌细胞对蛋白酶体的抑制或铜水平的变化比正常细胞更敏感。因此,具有蛋白酶体抑制功能的铜配合物的开发已成为一种有前途的抗癌策略。但是,关于铜抑制蛋白酶体的确切机理的信息尚有限。在这里,我们显示Cu(II)离子同时抑制分离的20S蛋白酶体的三种肽酶活性,其效力(IC50)在微摩尔范围内。在无细胞条件下,Cu(II)离子既不会催化氧化还原反应,也不会破坏20S蛋白酶体的组装,而是促进与通道门控受损相关的构象变化。值得注意的是,在补充了Cu(II)的培养基中生长的HeLa细胞显示出降低的蛋白酶体活性。但是,在抗氧化剂的存在下,这种作用减弱了。我们的结果表明,如果一方面Cu(II)抑制的20S活性可能与有利于核心颗粒闭合状态的构象变化有关,另一方面,Cu(II)离子在癌症中诱导的复杂作用细胞是几种同时发生的事件的结果,包括ROS介导的蛋白酶体泛滥,以及26S蛋白酶体分解为其20S和19S组分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号